WIC
EVH icon

Woodmont Investment Counsel’s Evolent Health EVH Stock Holding History

Woodmont Investment Counsel’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-700
Closed -$8K – 531
2015
Q4 		$8K Buy
+700
New +$10.3K ﹤0.01% 442

Other funds holding EVH

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Woodmont Investment Counsel's EVH Position: Q1 2016 in Review

Woodmont Investment Counsel sold out of Evolent Health (EVH) in Q1 2016, closing a stake of 700 shares — an estimated $8K sold.

Woodmont Investment Counsel first reported a position in EVH in Q4 2015 and held it in 1 quarter. The position peaked at $8K in Q4 2015. 70 funds tracked by Wall St. Rank hold EVH as of Q1 2016.

  • Woodmont Investment Counsel reported no remaining Evolent Health position as of Q1 2016 after selling out during the quarter.
  • Woodmont Investment Counsel sold 700 Evolent Health shares in Q1 2016, an estimated $8K.
  • Woodmont Investment Counsel first reported a position in Evolent Health in Q4 2015 and held it in 1 quarter.
  • Woodmont Investment Counsel's Evolent Health position peaked at $8K in Q4 2015.
  • 70 funds tracked by Wall St. Rank held Evolent Health as of Q1 2016.

Based on Woodmont Investment Counsel's 13F filing for Q1 2016, filed 16 May 2016.